Cytosorbents Corp. buy Quitte
Start price
22.12.16
/
50%
€5.14
Target price
22.06.17
€6.48
Performance (%)
-23.68%
End price
22.06.17
€3.92
Summary
This prediction ended on 22.06.17 with a price of €3.92. The price of Cytosorbents Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.68%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytosorbents Corp. | -6.358% | -6.358% | -59.851% | -90.299% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
Comments by Quitte for this prediction
In the thread Cytosorbents Corp. diskutieren
aktiviert
habe den Eindruck, diese Aktie ist jetzt zum Durchmarsch aktiviert
http://www.streetinsider.com/Corporate+News//Cytosorbents+%28CTSO%29+Announces+Launch+and+Initial+Sales+of+New+CytoSor/12358614.html
(Laufzeit überschritten)
Stopped prediction by Quitte for Cytosorbents Corp.
Cytosorbents Corp.
Start price
Target price
Perf. (%)
€9.12
06.11.18
06.11.18
€16.24
06.05.19
06.05.19
-24.33%
06.05.19
06.05.19
